Infections of the Central Line and Lock Therapy in Pediatric Oncological Children

被引:3
|
作者
Kabalan B, Paola [1 ]
Rodriguez Z, Natalie [2 ]
Tordecilla C, Juan [2 ]
Sepulveda R, Fanny [3 ]
机构
[1] Univ Chile, Becada Hematooncol Pediat, Hosp Roberto Rio, Santiago, Chile
[2] Univ Chile, Hosp Roberto Rio, Santiago, Chile
[3] Hosp Roberto Del Rio, Unidad Oncol, Santiago, Chile
来源
REVISTA CHILENA DE PEDIATRIA-CHILE | 2010年 / 81卷 / 05期
关键词
Lock Therapy; Central Venous Catheter; oncologic; children; infection;
D O I
10.4067/S0370-41062010000500006
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Introduction: The use of a permanent Central Venous Catheter (CL) in oncologic patients allows a secure and rapid access. Infection is an important risk. "Lock therapy" (LT) consists of the application of a high concentration of antibiotics in the lumen of the catheter, for the purpose of eradicating bacteria. Objective: To describe the use of LT associated with the systemic use of antibiotics in CL infections occurring among pediatric oncological patients. Methods: A descriptive, restrospective review of charts of children seen at the Oncology Unit, Roberto del Rio Children's Hospital, 2005 to 2007. Evaluated parameters included culture and sentitivity studies, removal of CL and mortality. Results: There were 11 episodes of infection associated to CL in 8 patients, most frequently associated to Staphylococcus coagulase-negative. The CL was preserved in 7 patients. There was no mortality associated to infection. Conclusion: For this group, LT and systemic antibiotics preserved the CL in most patients. Randomized prospective studies are needed in a larger population to support these findings.
引用
收藏
页码:425 / 431
页数:7
相关论文
共 50 条
  • [41] CONTROL, ALT, BUT DO NOT DELETE; THE ROLE OF ANTIMICROBIAL LOCK THERAPY (ALT) IN TREATING CENTRAL LINE INFECTIONS IN AN IRISH PAEDIATRIC HAEMATOLOGY/ONCOLOGY PATIENT COHORT
    Hyland, Meabh
    Tedford, Kara
    Curry, Sarah
    Alkhaaldi, Aisha
    PEDIATRIC BLOOD & CANCER, 2022, 69 : S356 - S357
  • [42] FIBRINOLYTIC THERAPY IN PEDIATRIC-ONCOLOGICAL PATIENTS
    JAKOB, P
    GROMBALL, J
    LEPPIK, KH
    BECK, JD
    MONATSSCHRIFT KINDERHEILKUNDE, 1985, 133 (08) : 605 - 605
  • [43] Art therapy: Experience in a pediatric oncological center
    Camera, F.
    Pinto, A.
    Gallo, S.
    Parlato, G.
    Barbuto, C.
    Orlando, R.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 66 - 66
  • [44] Antibiotic and other lock treatments for tunnelled central venous catheter-related infections in children with cancer
    Schoot, Reineke A.
    van Dalen, Elvira C.
    van Ommen, Cornelia H.
    van de Wetering, Marianne D.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (06):
  • [45] CENTRAL-LINE INFECTIONS
    Spencer, Maureen
    AMERICAN JOURNAL OF NURSING, 2014, 114 (12) : 13 - 13
  • [46] Should lock therapy always be avoided for central venous catheter-associated fungal bloodstream infections?
    Viale, P
    Petrosillo, N
    Signorini, L
    Puoti, M
    Carosi, G
    CLINICAL INFECTIOUS DISEASES, 2001, 33 (11) : 1947 - 1948
  • [47] Antibiotic lock therapy in central venous catheters
    Yazici, Nalan
    Akyuz, Canan
    Kupeli, Serhan
    Demir, Ahmet
    Buyukpamukcu, Munevver
    PEDIATRIC BLOOD & CANCER, 2007, 49 (04) : 514 - 514
  • [48] Attributable Mortality for Pediatric and Neonatal Central Line-Associated Bloodstream Infections in Greece
    Karagiannidou, Sofia
    Kourlaba, Georgia
    Zaoutis, Theoklis
    Maniadakis, Nikolaos
    Papaevangelou, Vassiliki
    JOURNAL OF PEDIATRIC INTENSIVE CARE, 2024, 13 (02) : 174 - 183
  • [49] It is time to address ambulatory central venous line infections in pediatric hematology/oncology patients
    Werner, Eric
    PEDIATRIC BLOOD & CANCER, 2017, 64 (02) : 221 - 222
  • [50] Assessing equity in preventing central line-associated bloodstream infections and surgical site infections in pediatric patients
    Song, Xiaoyan
    Levey, Deena
    Cheng, Jenhao Jacob
    Monteon, Monica
    Lee, Annette
    Harik, Nada
    Cora-Bramble, Denice
    Shah, Rahul K.
    ANTIMICROBIAL STEWARDSHIP & HEALTHCARE EPIDEMIOLOGY, 2025, 5 (01):